Advances in Anti-tumor Therapy of Myeloid-derived Suppressor Cells Combined with Immunological Checkpoint Inhibitors
Immunity checkpoint inhibitors (ICI) can enhance the original anti-tumor immune response by restoring the identification and killing of T cells to tumor cells. ICI have been approved for melanoma, NSCLC and renal cells carcinoma, etc. However, many patients do not respond to immunotherapy due to imm...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Magazine House of Cancer Research on Prevention and Treatment
2020-09-01
|
| Series: | Zhongliu Fangzhi Yanjiu |
| Subjects: | |
| Online Access: | http://html.rhhz.net/ZLFZYJ/html/8578.2020.19.1628.htm |